SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19

P Chen, A Nirula, B Heller, RL Gottlieb… - … England Journal of …, 2021 - Mass Medical Soc
… from the Blocking Viral Attachment and Cell Entry with SARS-CoV-2 Neutralizing Antibodies
(… We examined the effect of the neutralizing antibody on viral load, symptom scores, and …

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

R Shi, C Shan, X Duan, Z Chen, P Liu, J Song, T Song… - Nature, 2020 - nature.com
… , CR3022—a neutralizing antibody against SARS-CoV that was previously isolated from a
patient convalescing from SARS—was found to be cross-reactive with the SARS-CoV-2 RBD. …

[HTML][HTML] Neutralizing antibodies targeting SARS-CoV-2 spike protein

S Xiaojie, L Yu, Y Guang, Q Min - Stem cell research, 2021 - Elsevier
… In contrast to the antibodies from convalescent patient, in our lab, three potent SARS-CoV-2
neutralizing antibodies were screened from a combinatorial naïve library established 20 …

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

S Dispinseri, M Secchi, MF Pirillo, M Tolazzi… - Nature …, 2021 - nature.com
SARS-CoV-2 neutralization assay and the LIPS assay for the detection of IgG, IgM, and IgA
to SARS-CoV… coronaviruses, and to H1N1 influenza virus hemagglutinin. Our results indicate …

IgA dominates the early neutralizing antibody response to SARS-CoV-2

D Sterlin, A Mathian, M Miyara, A Mohr… - Science translational …, 2021 - science.org
… We confirmed that serum, BAL, and saliva antibodies have SARS-CoV-2 neutralization
potential using a pseudoneutralization assay and validated with a viral neutralization assay. It …

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston… - elife, 2020 - elifesciences.org
… -SARSCoV-2 agents. However, the degree to which SARS-CoV-2 will adapt to evade neutralizing
antibodies is … chimeric VSV/SARS-CoV-2 reporter virus, we show that functional SARS-…

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

J Seow, C Graham, B Merrick, S Acors, S Pickering… - Nature …, 2020 - nature.com
… of the neutralizing antibody response towards SARS-CoV-2 in some individuals. In contrast,
individuals with high peak ID 50 for neutralization maintain neutralizing antibody titres in the …

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo… - Nature, 2020 - nature.com
coronavirus. Here we report the isolation of sixty-one SARS-CoV-2-neutralizing monoclonal
antibodies from five patients infected with SARS-CoV-2 and admitted to hospital with severe …

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

F Wu, A Wang, M Liu, Q Wang, J Chen, S Xia, Y Ling… - MedRxiv, 2020 - medrxiv.org
… , indicating that the antigenicity of SARS-CoV-2 is different from that of SARS-CoV. … that
cross-neutralizing antibodies targeted the conserved epitopes of SARS-CoV and SARS-CoV-2 …

[HTML][HTML] Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

G Zhou, Q Zhao - International Journal of Biological Sciences, 2020 - ncbi.nlm.nih.gov
neutralizing antibodies (NAbs) against SARS-CoV-2 will be greatly important therapeutic
agents for the treatment of coronavirus … Herein, the host immune responses against SARS-CoV